Latest Content

10 of 498 Shown
  • Contemporary Management of HIV: New Data From CROI 2017

    In this downloadable slideset, Charles B. Hicks, MD, and Program Director Joseph J. Eron, Jr., MD, review key new HIV data presented at the Seattle 2017 meeting.

    Topics include:
    -New data on currently available ART
    -Switch/simplification strategies for virologically suppressed patients
    -Investigational ARV agents
    -Treatment complications and comorbidities
    Date Posted: 4/26/2017
  • Contemporary Management of HIV: Management of HIV in Women

    In this downloadable slideset, Kathleen E. Squires, MD, and Program Director Joseph J. Eron, Jr., MD, review key data and optimal strategies in caring for HIV-infected women, including ART safety and efficacy in women, reproductive health management, ART and pregnancy, and preventing HIV infection in women.
    Date Posted: 4/25/2017
  • Contemporary Management of HIV: Management of Aging Patients

    In this downloadable slideset, Edgar Turner Overton, MD, and Program Director Joseph J. Eron, Jr., MD, review key data on managing aging patients with HIV.
    Date Posted: 4/24/2017
  • How New Data From CROI 2017 May Inform Switch Strategies in HIV-Infected Patients With Poor Bone Health

    Charles B. Hicks MD - 4/21/2017
    Is switching TDF to TAF justified in osteopenic women?
  • How New Data From CROI 2017 May Renew Interest in NNRTIs

    Charles B. Hicks MD - 4/21/2017
    How do phase III data on doravirine affect the potential for future therapy with NNRTIs?
  • Optimal ART During Late Pregnancy After a Break in Therapy

    Kathleen E. Squires MD - 4/20/2017
    Which regimen may work best during the third trimester?
  • How New Data From CROI 2017 May Inform Treatment Simplification Options

    Charles B. Hicks MD - 4/20/2017
    Is the switch to a 2-drug regimen in virologically suppressed HIV-infected patients feasible?
  • The Promise of Long-Acting Injectable Antiretroviral Therapies

    Paul E. Sax MD - 4/12/2017
    Will long-acting cabotegravir plus rilpivirine injections satisfy patient desire for less frequent dosing? Here is my take.
  • An Aging Woman With Renal Disease and BMD Concerns: Is Dual Therapy an Option?

    Paul E. Sax MD - 4/11/2017 1 comment / Last Comment: 4/22/2017
    Here is my take on current data with dual-therapy regimens and when they might be considered.
  • Identifying At-Risk Patients and Diagnosing Active TB Infection in the Primary Care Setting

    In this multimedia module designed for primary care providers, Richard E. Chaisson, MD, identifies patients at increased risk for active TB infection and reviews key tests in diagnosing active TB. After reviewing this presentation, be sure to consult inPractice HIV and inPractice HIV Africa for comprehensive details on TB epidemiology, diagnosis, and management.
    Date Posted: 4/10/2017
10 of 498 Shown
Show 10 More
Decision Support
Immediate answers to treatment questions
More than just up to date